ION BEAM APPLICATIONS (IBAB.BR) Stock Fundamental Analysis
Europe - Euronext Brussels - EBR:IBAB - BE0003766806 - Common Stock
12.78 EUR
+0.64 (+5.27%)
We assign a fundamental rating of 4 out of 10 to IBAB. IBAB was compared to 62 industry peers in the Health Care Equipment & Supplies industry. While IBAB is still in line with the averages on profitability rating, there are concerns on its financial health. IBAB has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year IBAB was profitable.
IBAB had a positive operating cash flow in the past year.
Of the past 5 years IBAB 4 years were profitable.
In multiple years IBAB reported negative operating cash flow during the last 5 years.
1.2 Ratios
IBAB has a Return On Assets of 2.71%. This is comparable to the rest of the industry: IBAB outperforms 45.16% of its industry peers.
IBAB has a better Return On Equity (14.29%) than 82.26% of its industry peers.
With an excellent Return On Invested Capital value of 15.54%, IBAB belongs to the best of the industry, outperforming 93.55% of the companies in the same industry.
IBAB had an Average Return On Invested Capital over the past 3 years of 6.20%. This is below the industry average of 9.74%.
The last Return On Invested Capital (15.54%) for IBAB is above the 3 year average (6.20%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROIC | 15.54% |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
1.3 Margins
IBAB's Profit Margin of 2.85% is in line compared to the rest of the industry. IBAB outperforms 41.94% of its industry peers.
IBAB's Profit Margin has declined in the last couple of years.
IBAB has a Operating Margin of 6.48%. This is comparable to the rest of the industry: IBAB outperforms 46.77% of its industry peers.
IBAB's Operating Margin has improved in the last couple of years.
IBAB has a Gross Margin of 31.21%. This is amonst the worse of the industry: IBAB underperforms 82.26% of its industry peers.
IBAB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% |
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
2. Health
2.1 Basic Checks
IBAB has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
IBAB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IBAB has less shares outstanding
Compared to 1 year ago, IBAB has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.65, we must say that IBAB is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.65, IBAB is doing worse than 66.13% of the companies in the same industry.
IBAB has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
IBAB's Debt to Equity ratio of 0.23 is fine compared to the rest of the industry. IBAB outperforms 64.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.65 |
ROIC/WACC2.14
WACC7.26%
2.3 Liquidity
IBAB has a Current Ratio of 0.94. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
IBAB's Current ratio of 0.94 is on the low side compared to the rest of the industry. IBAB is outperformed by 85.48% of its industry peers.
IBAB has a Quick Ratio of 0.94. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of IBAB (0.62) is worse than 85.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
IBAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 112.86%, which is quite impressive.
The Earnings Per Share has been growing slightly by 3.99% on average over the past years.
IBAB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.96%.
Measured over the past years, IBAB shows a quite strong growth in Revenue. The Revenue has been growing by 12.01% on average per year.
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
3.2 Future
The Earnings Per Share is expected to grow by 58.72% on average over the next years. This is a very strong growth
IBAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.63% yearly.
EPS Next Y141.9%
EPS Next 2Y109.12%
EPS Next 3Y67.72%
EPS Next 5Y58.72%
Revenue Next Year23.68%
Revenue Next 2Y13.14%
Revenue Next 3Y10.36%
Revenue Next 5Y2.63%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 22.42, the valuation of IBAB can be described as rather expensive.
IBAB's Price/Earnings ratio is a bit cheaper when compared to the industry. IBAB is cheaper than 79.03% of the companies in the same industry.
IBAB's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.84.
A Price/Forward Earnings ratio of 12.11 indicates a correct valuation of IBAB.
Based on the Price/Forward Earnings ratio, IBAB is valued cheaper than 82.26% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.40, IBAB is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.42 | ||
| Fwd PE | 12.11 |
4.2 Price Multiples
IBAB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IBAB is cheaper than 85.48% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.32 |
4.3 Compensation for Growth
IBAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IBAB's earnings are expected to grow with 67.72% in the coming years.
PEG (NY)0.16
PEG (5Y)5.63
EPS Next 2Y109.12%
EPS Next 3Y67.72%
5. Dividend
5.1 Amount
IBAB has a Yearly Dividend Yield of 1.38%.
Compared to an average industry Dividend Yield of 1.11, IBAB pays a bit more dividend than its industry peers.
IBAB's Dividend Yield is slightly below the S&P500 average, which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.38% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
8.05% of the earnings are spent on dividend by IBAB. This is a low number and sustainable payout ratio.
DP8.05%
EPS Next 2Y109.12%
EPS Next 3Y67.72%
EBR:IBAB (12/29/2025, 5:28:41 PM)
12.78
+0.64 (+5.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap386.98M
Revenue(TTM)596.63M
Net Income(TTM)17.00M
Analysts80
Price Target14.62 (14.4%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.38% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.27%
PT rev (3m)-2.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-13.91%
EPS NY rev (3m)-10.89%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.04%
Revenue NY rev (3m)1.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.42 | ||
| Fwd PE | 12.11 | ||
| P/S | 0.65 | ||
| P/FCF | N/A | ||
| P/OCF | 139 | ||
| P/B | 3.25 | ||
| P/tB | 4.1 | ||
| EV/EBITDA | 8.32 |
EPS(TTM)0.57
EY4.46%
EPS(NY)1.06
Fwd EY8.26%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.09
OCFY0.72%
SpS19.7
BVpS3.93
TBVpS3.12
PEG (NY)0.16
PEG (5Y)5.63
Graham Number7.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROCE | 25.19% | ||
| ROIC | 15.54% | ||
| ROICexc | 16.45% | ||
| ROICexgc | 19.79% | ||
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% | ||
| FCFM | N/A |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.2%
ROIC(5y)6.71%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)10.93%
ROICexgc growth 3YN/A
ROICexgc growth 5Y52.5%
ROICexc growth 3Y-88.2%
ROICexc growth 5Y50.32%
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
F-Score7
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.54 | ||
| Cap/Depr | 65.94% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 5.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 1.65 |
F-Score7
WACC7.26%
ROIC/WACC2.14
Cap/Depr(3y)79.57%
Cap/Depr(5y)64.6%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.86%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%75.35%
EPS Next Y141.9%
EPS Next 2Y109.12%
EPS Next 3Y67.72%
EPS Next 5Y58.72%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%47.7%
Revenue Next Year23.68%
Revenue Next 2Y13.14%
Revenue Next 3Y10.36%
Revenue Next 5Y2.63%
EBIT growth 1Y38.72%
EBIT growth 3Y27.16%
EBIT growth 5Y65.71%
EBIT Next Year221.54%
EBIT Next 3Y67.42%
EBIT Next 5Y52.9%
FCF growth 1Y90.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y105.87%
OCF growth 3YN/A
OCF growth 5YN/A
ION BEAM APPLICATIONS / IBAB.BR FAQ
Can you provide the ChartMill fundamental rating for ION BEAM APPLICATIONS?
ChartMill assigns a fundamental rating of 4 / 10 to IBAB.BR.
What is the valuation status for IBAB stock?
ChartMill assigns a valuation rating of 5 / 10 to ION BEAM APPLICATIONS (IBAB.BR). This can be considered as Fairly Valued.
How profitable is ION BEAM APPLICATIONS (IBAB.BR) stock?
ION BEAM APPLICATIONS (IBAB.BR) has a profitability rating of 5 / 10.
What is the valuation of ION BEAM APPLICATIONS based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ION BEAM APPLICATIONS (IBAB.BR) is 22.42 and the Price/Book (PB) ratio is 3.25.
What is the earnings growth outlook for ION BEAM APPLICATIONS?
The Earnings per Share (EPS) of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 141.9% in the next year.